MSA
AERI

Mason Street Advisors’s Aerie Pharmaceuticals AERI Stock Holding History

Mason Street Advisors’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-104,330
Closed -$3.04M – 1768
2014
Q4 		$3.04M Hold
104,330
– – 0.02% 764
2014
Q3 		$2.16M Buy
104,330
+14,690
+16% +$290K 0.02% 918
2014
Q2 		$2.22M Hold
89,640
– – 0.02% 916
2014
Q1 		$1.9M Buy
+89,640
New +$1.81M 0.02% 974

Other funds holding AERI

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Mason Street Advisors's AERI Position: Q1 2015 in Review

Mason Street Advisors sold out of Aerie Pharmaceuticals (AERI) in Q1 2015, closing a stake of 104,330 shares — an estimated $3.04M sold.

Mason Street Advisors first reported a position in AERI in Q1 2014 and held it in 4 quarters. The position peaked at $3.04M in Q4 2014. 123 funds tracked by Wall St. Rank hold AERI as of Q1 2015.

  • Mason Street Advisors reported no remaining Aerie Pharmaceuticals position as of Q1 2015 after selling out during the quarter.
  • Mason Street Advisors sold 104,330 Aerie Pharmaceuticals shares in Q1 2015, an estimated $3.04M.
  • Mason Street Advisors first reported a position in Aerie Pharmaceuticals in Q1 2014 and held it in 4 quarters.
  • Mason Street Advisors's Aerie Pharmaceuticals position peaked at $3.04M in Q4 2014.
  • 123 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q1 2015.

Based on Mason Street Advisors's 13F filing for Q1 2015, filed 15 May 2015.